RecruitingNCT02917707

Integrative Analysis of CRC Liver Metastasis


Sponsor

Da Fu

Enrollment

1,000 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators will perform integrative analysis of CRC liver metastasis


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study collects tissue samples and health information from patients with colorectal cancer (bowel cancer) that has spread to the liver, to better understand the biology of these liver metastases and find new targets for treatment. **You may be eligible if...** - You are 75 years old or younger - You have been diagnosed with colorectal cancer (confirmed by biopsy) - You are in good physical health (able to perform daily activities) - You have not previously received chemotherapy for this cancer **You may NOT be eligible if...** - You are 76 years old or older - You have already had chemotherapy for this cancer - You have serious heart, liver, kidney, or other organ problems - You are in poor overall health Understanding the biology of bowel cancer that has spread to the liver is key to developing better treatments for this challenging condition. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERnormal colorectal tissues

The investigators will extract total protein, DNA and RNA from these groups.


Locations(2)

Ganzhou City People's Hospital

Ganzhou, Jiangxi, China

Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02917707


Related Trials